Carmignac Gestion’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Carmignac Gestion's PFE Position: Q3 2026 in Review
Carmignac Gestion reduced its Pfizer (PFE) stake by 26% in Q3 2026, selling an estimated $132K and leaving 14,495 shares worth $413K. The position accounts for 0.01% of the portfolio, ranked #114.
Carmignac Gestion first reported a position in PFE in Q3 2019 and has held it in 9 quarters since. The position peaked at $137M in Q1 2022. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Carmignac Gestion held 14,495 shares of Pfizer worth $413K as of Q3 2026.
- Carmignac Gestion sold 4,980 Pfizer shares in Q3 2026, an estimated $132K.
- Pfizer made up 0.01% of Carmignac Gestion's portfolio in Q3 2026, its #114 holding.
- Carmignac Gestion first reported a position in Pfizer in Q3 2019 and has held it in 9 quarters since.
- Carmignac Gestion's Pfizer position peaked at $137M in Q1 2022.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Carmignac Gestion's 13F filing for Q3 2026, filed 13 Nov 2026.